These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2845544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of two leukotriene antagonists in rat traumatic shock.
    Levitt MA, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA, Lefer AM.
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
    Karasawa A, Rochester JA, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H, Stahl GL, Lefer AM.
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beneficial effects of a neutral protease inhibitor in traumatic shock.
    Hock CE, Lefer AM.
    Pharmacol Res Commun; 1985 Mar; 17(3):217-26. PubMed ID: 4011646
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protective actions of nafazatrom in traumatic shock.
    Lefer AM, Messenger M.
    Arzneimittelforschung; 1982 Mar; 32(9):1089-91. PubMed ID: 6890831
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
    Bitterman H, Phillips GR, Dragon G, Lefer AM.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protective actions of aprotinin in acute traumatic shock.
    Araki H, Lefer AM.
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.